Evaluation of Patient Driven Digital Mole Monitoring by Marfurt, Severin
Universitätsspital Zürich 
Klinik für Dermatologie 
Direktor: Prof. Dr. med. Lars French 
Betreuung der Masterarbeit: Prof. Dr. med. Ralph Braun 
Leitung der Masterarbeit: Prof. Dr. med. Ralph Braun  
 
 
 
 
 
 
Evaluation of Patient Driven Digital Mole Monitoring 
 
 
 
 
 
MASTERARBEIT 
zur Erlangung des akademischen Grades 
Master of Medicine (M Med) 
der Medizinischen Fakultät der Universität Zürich 
 
 
 
 
 
 
vorgelegt von 
Severin Marfurt (13-919-972) 
 
2018 
 
 2 
Table of Contents 
1. Abstract ................................................................................................................. 3 
2. List of Abbreviations ............................................................................................ 4 
3. Introduction ........................................................................................................... 5 
3.1. Skin Cancer – Epidemiological Situation and Challenges 5 
3.2. Development in Diagnostics 6 
3.3. Goals of the Project 8 
4. Materials and Methods ......................................................................................... 9 
4.1. Design 9 
4.2. Setting 9 
4.3. Participants 16 
4.4. Definitions 16 
4.5. Statistics 17 
4.6. Ethics 17 
5. Current Points of View and Development in Diagnostics ............................... 19 
5.1. Already Established: Sequential Digital Dermoscopy Imaging („Monitoring“; SDDI) 19 
5.2. Emerging Approaches for Professionals 22 
5.3. Approaches for Patients: Devices for Smartphones and Applications 25 
6. Results ................................................................................................................. 27 
6.1. Concordance between Patients and Expert Dermatologist 30 
6.2. Influence of Feedback on the Concordance 30 
6.3. Further Comparisons of the Concordance 31 
6.4. Patients’ Attitudes towards Patient Driven Monitoring 32 
7. Discussion ........................................................................................................... 33 
7.1. Key Findings 33 
7.2. Comparison to Other Papers 34 
7.3. Strength and Limitations 35 
7.4. Implications of the Paper and Outlook 37 
8. References ........................................................................................................... 39 
9. Acknowledgment ................................................................................................ 42 
10. Curriculum Vitae ................................................................................................. 43 
11. Declaration........................................................................................................... 44 
12. Attachments ........................................................................................................ 45 
 3 
1. Abstract 
Introduction: The incidence of malignant melanoma is still rising. Besides high mor-
tality, malignant melanoma causes a growing economic burden on many health care 
systems. Primary prevention measures already being widely accepted nowadays, the 
focus now lies on secondary prevention, especially on earlier detection. Not only are 
there new diagnostic possibilities for professionals, but also do patients get more and 
more involved in the diagnostic process. Smartphone applications allow patients to 
monitor their moles. However, so far there is little known about the impact of these 
applications and the feasibility of patient driven mole monitoring in general.  
Methods: After an overview of the established diagnostics of melanoma and some 
relevant new approaches for professionals and patients, this paper contains a data 
collection part. In form of a feasibility study, a web-based survey taught participants 
about mole monitoring and then presented them cases of combined follow-up imag-
es. Participants were asked to evaluate whether or not a mole had changed signifi-
cantly. The primary endpoint was defined to be the overall concordance of the as-
sessments of patients with the ones of an expert dermatologist.  
Results: 47 recruited volunteers and 19 participants with a dermatological back-
ground contributed 799 and 292 assessed images respectively. Looking at the over-
all concordance of patients completing the survey with the assessment of the expert 
dermatologist, a score of 80.42 % (confidence interval 76.912 – 83.922 %) was 
reached (mean = 24.13, standard deviation = 2.49, median = 24.00 (17.00 - 29.00)). 
Conclusions: Many of the papers evaluating the new diagnostic tools conclude a 
great potential but criticise the often missing underlying evidence. As this paper 
shows, patient education for mole monitoring seems in a tendency feasible and also 
favoured by many patients. Against the backdrop of dwindling resources in many 
health care systems, self-monitoring might be a way for patients to take responsibility 
themselves. Although the participants in this paper did not reach the overall concord-
ance of 90 % previously defined as significant, the result can be regarded as re-
spectable. Thus, and because sample sizes are small, results can only be interpreted 
as tendencies and in a speculative manner. For a better significance and quantifica-
tion of the impact of teaching as well as the feasibility of patient driven monitoring, 
more extensive studies should be conducted taking up our approach. 
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2. List of Abbreviations 
NMSC  Nonmelanoma skin cancer 
BCC   Basal cell carcinoma 
SCC   Squamous cell carcinoma  
UV   ultraviolet  
SDDI   Sequential digital dermoscopy imaging 
ST-SDDI  Short-term sequential digital dermoscopy imaging 
LT-SDDI  Long-term sequential digital dermoscopy imaging 
PCP   Primary care physician 
RCM   Reflectance confocal microscopy  
EIS   Electrical impedance spectroscopy  
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3. Introduction 
3.1. Skin Cancer – Epidemiological Situation and Challenges  
The incidences of skin cancer, both melanoma and nonmelanoma skin cancer 
(NMSC), are still rising. Nonmelanoma skin cancer includes basal cell carcinoma 
(BCC) as well as squamous cell carcinoma (SCC). In white populations throughout 
the world, the incidence rates of cutaneous melanoma even increase the most rapid-
ly over all cancers.(1, 2) An estimated annual increase between 3 and 7 % suggests 
that the incidence is going to double every 10-20 years.(1) Switzerland being ranked 
third place in 2012, the two highest incidence rates in the world are found in Australia 
and New Zealand where they have gone up to 60/100’000 and where consequently, 
cutaneous melanoma is one of the most frequent cancer types of them all.(2, 3, 4) Un-
derstandably, this has a considerable impact on the economic burden of disease. 
 
Melanomas develop from neural crest-derived melanocytes, pigmented cells that are 
usually located in the epidermis, and sometimes in the dermis.(5) Although some as-
pects of the aetiology of melanoma are still not completely understood or sufficiently 
quantified, the predominant environmental risk factor has been shown to be the ex-
posure to ultraviolet (UV) radiation.(5, 6) Studies indicate that an intermittent form of 
sun exposure that leads to irregular but intense contact with UV radiation increases 
the risk of melanoma, whereas a steady or chronic exposure seems to be paradoxi-
cally inversely associated with melanoma.(6) In addition to familiar predisposition 
which contributes only approximately 5-10 % to the total number of melanoma cases, 
individual factors such as sex, skin type or sunburn play an essential role.(5) The fact 
that the association between melanoma and sunburn history has turned out to be 
stronger in studies including a higher percentage of fair-skinned controls confirms 
that there is also a geographical component when it comes to risk factors of mela-
noma. The reason for this is that the proportion of fair-skinned individuals in a popu-
lation grows with increasing latitude.(5, 6) What is missing so far in the list of risk fac-
tors are the various life style parameters such as outdoor/indoor life, sunburn or vit-
amin D and antioxidant protection.(6) Amongst these life style factors, there are sev-
eral that underwent change in our society simultaneously with the beginning and still 
ongoing increase of melanoma incidence, for instance when it comes to the habits in 
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leisure activity or places of work (indoor and outdoor). That is where the primary pre-
vention begins. Cautious sun exposure is regarded as the most straightforward 
measure to protect from skin damage and includes avoidance of the midday’s sun, 
solarium visits, the use of adequate clothing, sunhats and sunglasses and appropri-
ate sunscreen agents.(7) Apparently, these recommendations were not even enough 
to slow down the increase of incidence rates of melanoma. However, the acceptance 
of sun exposure as a danger came up after a general unawareness of this correlation 
before 1990.(6)    
In contrast, secondary melanoma prevention aims at detecting an already developing 
melanoma as early as possible. New technologies with auspicious approaches are 
deployed when it comes to the detection of melanoma. However, it needs to be con-
sidered that the increase in melanoma incidence cannot merely be led back to better 
methods in recording data or to changes in diagnostic criteria.(8) While some studies 
propose a stabilization or even decrease of mortality rates from cutaneous melanoma 
as a consequence of earlier detection,(1, 9) a recent analysis in the US showed that 
the incidence of invasive melanoma increases on a lower level than the mortality rate 
which means that we might not yet see the efforts of an earlier detection.(10)   
Nevertheless, it should be emphasised that the incidences of melanoma in situ and 
thinner invasive melanoma increase faster than that of thicker invasive melanoma, 
which can be interpreted as a benefit of earlier detection.(2, 9, 10)   
In an Italian study, 40.6 % of enrolled melanoma patients recognized the lesion as 
being suspicious of melanoma themselves, in 12.5 % of the cases it was their 
spouse. This underlines why melanoma early diagnosis strategies, which secondary 
melanoma prevention is aiming at, should absolutely include the patients themselves 
with their ability to detect change of a mole. Moreover, it emphasises the role of skin 
self-examination and mole monitoring.(11)  
3.2. Development in Diagnostics  
Dermatologists with a certain amount of experience can diagnose most of the mela-
nocytic lesions with the unaided eye.(12) In uncertain cases they often use dermosco-
py in addition but nonetheless, even in combination there is still no diagnostic accu-
racy of 100 %. To be sure, histopathological examination is needed which remains 
the gold standard in the diagnosis. However, in patients with multiple and many sus-
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picious melanocytic lesions it is somewhat impractical to excise all of the lesions to 
have them examined by the histopathologist.(12) In order to prevent benign lesions 
from being excised and to detect changes that indicate malignancy, dermatoscopic 
monitoring is being used. This technique enables a detailed view of subsurface struc-
tures and furthermore a comparison over time. This technique is supposed to help 
diagnose melanoma early since change is a highly sensitive marker for melanoma.(13) 
Until some years ago, devices for digital dermoscopic monitoring had been reserved 
for professionals. However, attachments to smart phones have become available 
recently as well as applications that take and afterwards store pictures of moles even 
without attachments using different technical approaches (see chapter 5.3). Thus, it 
might only be a question of time until patients will extensively start using these new 
possibilities.  
Although different aspects of the melanoma development still remain unclear, it is 
widely believed that varying degrees of dysplasia precede the process of malignant 
transformation in the tumour entity melanoma as well. Nevertheless, in the majority of 
melanomas there is no evidence or no clear anamnesis of a pre-existing melanocytic 
nevus at the later melanoma site.(14) The percentage of the melanocytic nevus com-
ponent lies between 10.8 % and 57.6 % according to the data published in scientific 
literature.(14) Surprisingly, amongst the pre-stages before malignant transformation, 
the dysplastic nevus has not been found most often. Dermal and congenital nevi 
have been reported as being the most prevalent types.(14) An other recent study from 
Turkey states that most melanomas develop de novo.(15)  
Breaking this down to the diagnostic process, this means that melanoma can be dis-
covered either as a newly evolving lesion or as a changing lesion that already existed 
before as a form of a melanocytic nevus. If a lesion appears out of nothing, it may 
lead the patient to a doctor sooner or later or directly to a dermatologist, but if a pre-
existing lesion undergoes change that has to be noticed first. Either dermatologists 
detect it during a routine skin control or in the context of a screening programme or 
the patients themselves notice the change. When it comes to secondary melanoma 
prevention, patients at risk are controlled more often nowadays. And to make it more 
likely that patients detect change of a lesion on their own, there are devices and 
smart phone applications coming on the market. They are supposed to help patients 
observing moles or assessing moles they consider suspicious somehow. In an Italian 
study, 40.6 % of melanomas have apparently already been detected by the patients 
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themselves, presumably without any further technical support.(11) Thus, there seems 
to be enormous potential for a better and earlier detection thanks to these upcoming 
devices and possibilities. At the same time, physicians might increase their sensitivity 
in detecting changing moles and melanoma in general by introducing new and ad-
junct techniques in their routine work (see chapter 5.2). It would be highly gratifying if 
these developments finally succeeded in decreasing or at least stabilizing mortality 
rates of melanoma patients. However, in order for a new technique to be established, 
requirements must be met and it needs to be applied correctly. 
3.3. Goals of the Project 
In a first part, this project intends to give an overview of the current professional ap-
proaches in the detection of suspicious moles, established routines as well as the 
mentioned newly evolving techniques. Moreover, the project wants to discuss how 
patients themselves can contribute to an earlier detection, which is the main effort of 
secondary melanoma prevention.   
In a second part, the paper discusses the results of a conducted survey evaluating 
aspects of the feasibility of mole monitoring by patients themselves.  
Over the whole of the project, the following questions were addressed:  
1) What is sequential digital dermoscopy imaging („monitoring“) exactly and what is 
its significance in skin cancer diagnostics for professionals and patients? 
2) Are patients able to assess whether or not a lesion has changed significantly in 
short- or long-term monitoring when comparing follow-up and baseline pictures of the 
same lesion after an initial short tutorial explaining how to do so? Is digital follow-up 
feasible by patients themselves? 
3) Is there a difference in the performance of participants who got feedback to each 
of their assessments in comparison to those who did not?  
4) What is the patients’ view on the subject?   
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4. Materials and Methods 
4.1. Design 
The paper is considered a feasibility study. It is a small research project using al-
ready existing health-related, anonymous and non-genetic data. The collection of 
new data for the study part of this paper has been conducted in form of a web-based 
survey to which recruited participants found access over an URL (uniform resource 
locator) or a QR-code (quick response code). For the theoretical part about the point 
of view and current development in diagnostics at the beginning of the paper, litera-
ture and publications found mainly on PubMed were considered as well as direct in-
formation, for instance in form of brochures and material from manufacturers them-
selves.  
4.2. Setting  
The data collection part of this paper is based on data gained through a survey which 
we created from scratch on the platform SurveyMonkey (SurveyMonkey Inc., San 
Mateo, California, USA, www.surveymonkey.com). It consisted of three major parts. 
After a short introduction informing the participant about the purpose and the idea 
behind the study and some statistical questions and superficial questions concerning 
their own mole history, there was first a tutorial. This tutorial contained relevant in-
formation about dermoscopy, its significance and the different types of mole monitor-
ing, that is short-term sequential digital dermoscopy imaging (ST-SDDI) and long-
term sequential digital dermoscopy imaging (LT-SDDI). Moreover, it was explained to 
the participants what “change” regarding moles means and which forms of change 
are considered to be significant and non-significant using the criteria Kittler and Men-
zies defined in 2005 (see chapter 5.1).(12) Then some examples with explanations 
followed for the participants to get familiar with the criteria (see illustrations 3-8 taken 
from the survey at the end of this subchapter). An “example” consisted of two se-
quential dermoscopy images of the same mole that had been aligned precisely next 
to each other and combined into one single image. The left side displayed the initial 
baseline picture whereas the right side displayed the follow-up picture of the lesion 
(see illustration 1). The pictures had been provided by a database in Sydney,  
Australia.  
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Second, a test set containing 10 of these examples followed, where the participants 
were supposed to practise and deepen their knowledge acquired in the preceding 
tutorial. They were always asked the same question, whether or not the mole shown 
has in their opinion changed significantly over the period of time between the base-
line and the follow-up picture. Every answer was immediately registered via the 
online platform and they got a feedback whether their answer had been correct or 
not. After the completion of the test set, the participants were asked how familiar they 
felt so far with the assessment of moles in terms of change in accordance with the 
criteria studied in the tutorial and repeated in the test set. If they answered “familiar” 
or “rather familiar”, they were forwarded to the third part of the survey, which is the 
main survey. The main survey contained 30 examples that the participants had to 
assess in the same way as before in the test set. In case they answered “rather un-
familiar” or “unfamiliar”, they were asked whether they wanted to quickly go through 
tutorial and test set again in order to hopefully feel more familiar afterwards and then 
start the main survey or if they wanted to abandon without participating in the main 
survey and thereby without contributing data to the study.   
Illustration 1: Example of a follow-up case presented to the participants  
Although in clinical practice, the rate of significant changes in moles is only around 
10 %, we included more cases with change in order to prevent the participants from 
getting bored and losing focus. We thereby tried to find a balance and to include 
enough events to keep the participants’ engagement high without presenting a ridicu-
lous situation that would never occur. Bearing in mind that participants would proba-
bly not compare an endless number of images attentively, we thought of scheduling a 
total of 30 cases. Among these, 6 cases (= 20 %) showed an event in form of signifi-
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cant change.   
After the completion of the survey, the participants were conclusively asked whether 
or not they could at all imagine observing their own moles in the foreseeable future, 
for instance by using upcoming applications working with the technique of monitoring. 
The participants completed different variants of the survey. In variant 1 they got 
feedback on whether or not their answer had been correct after assessing every ex-
ample in the main survey, in variant 2 they did not get a feedback. In the test set they 
got feedback in both variants. Thereby, the influence of feedback on the performance 
of the participants was supposed to be evaluated in order to shed light on how the 
optimal preparation for self-monitoring should look like. The participants randomly 
took or got a flyer with a URL and a QR code leading directly to either variant 1 or 
variant 2 (see illustration 2 for the visualised logic circuit of the survey).   
The participants with a dermatological background were led to a separate collector of 
the feedback version of the survey. Thereby, a maximal learning effect was sup-
posed to be provided, mainly for younger colleagues who might not have a lot of ex-
perience in monitoring yet. 
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Illustration 2: Visualisation of the logic circuit of the survey  
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Illustration 3: Part of the tutorial, example 1 with comments (in German) 
 
Illustration 4: Part of the tutorial, example 2 with comments (in German) 
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Illustration 5: Part of the tutorial, example 3 with comments (in German) 
 
Illustration 6: Part of the tutorial, magnification of example 3 
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Illustration 7: Part of the tutorial, example 4 with comments (in German) 
 
Illustration 8: Part of the tutorial, magnification of example 4 
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4.3. Participants 
The participants of the survey which provided data for the data collection part of this 
paper were recruited on a completely voluntary basis. In a first attempt, patients of 
the mole consultation at the University Hospital of Zurich were informed about the 
existence of the project. This happened in an oral way during or mainly after a con-
sultation or via a flyer which was distributed and displayed in the waiting room (see 
attachment). Furthermore, in the context of an information event for patients on the 
subject of skin cancer in general, the possibility of an anonymous participation was 
mentioned and encouraged. Whether a patient got the link for the feedback or the no 
feedback version of the survey was completely random. The only exclusion criterion 
was non-understanding of German language. In a second round, dermatologists, fu-
ture dermatologists and medical students doing an internship in dermatology (“Un-
terassistenten”) got access to the survey in a separate collector. The link was sent in 
an internal email to the medical personnel of the dermatology department of the Uni-
versity Hospital Zurich. They went through a feedback version of the survey in order 
to have a maximum of educational effect for the many younger colleagues.   
4.4. Definitions 
The primary endpoint of the study part of the paper was to find out if patients were 
able to assess whether or not a lesion in short- or long-term monitoring has changed 
significantly when comparing follow-up and baseline pictures of the same lesion after 
a short tutorial on how to do so. Significance of this endpoint was previously defined 
as more than 90 % concordance with the assessment by an expert dermatologist 
(Prof. Dr. med. Scott W. Menzies), seen over all observations. In the best case, each 
participant who completed the survey contributed 30 observations since the main 
survey part consisted of 30 cases.    
Additional secondary endpoints were the difference of concordance between the 
group with feedback after every assessment and the other group without feedback as 
well as the difference of concordance between the overall concordance of patients 
and in contrast to the participants with dermatological background.  
Moreover, the attitude of the participants towards the aspect of self-monitoring was of 
peculiar interest.  
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4.5. Statistics 
Before starting the survey, some careful statistical considerations regarding sample 
size and power estimation have been made. The data set was determined to contain 
30 observations. The proportion of change in the dataset was defined to be 20 % (or 
6 out of 30 cases). Thus, the only parameter about to change was considered the 
number of enrolled participants or the number of observations respectively since not 
every participant assessed all 30 cases. It was considered a paired agreement study 
with a dichotomous outcome for both the gold standard (0 = no change, 1 = change) 
and the change variable for the evaluations of the participants (0 = no change, 
1 = change). To calculate a proportion of overall concordance, the 0/0 and 1/1 obser-
vations were added.   
For the following analysis of data, SurveyMonkey (SurveyMonkey Inc., San Mateo, 
California, USA), Excel (Version 2010; Microsoft Cooperation, Redmond, Washing-
ton, USA) and SPSS (IBM SPSS Statistics for Windows, Version 22.0; IBM Corp, 
Armonk, New York, USA) were used for descriptive statistics and t-test for the com-
parison of the different subgroups.   
4.6. Ethics 
We exclusively used dermoscopic (close up) images of individual lesions from a re-
search database at the Sydney Melanoma Diagnostic Centre. The Australian patients 
remain completely anonymous as only the skin lesions are visible in the images with-
out any hints of the personality, not even disclosing the exact anatomic site of the 
lesion. Moreover, these patients had given their consent that the images could be 
used for the purpose of research later on. The usage of their provided images had no 
influence on the patients’ treatment since they were chosen retrospectively and ther-
apeutic management had already been decided. Neither had the project any influ-
ence on the treatment of the participants completing the survey.  
At the beginning of the survey, the participants were asked to fill in some demograph-
ic and statistical information about themselves such as sex, approximate age or the 
information whether they had ever shown a mole to a doctor or had had one excised 
before. Nevertheless, the reply to all these questions was voluntary and no further 
information about their personality or identity was inquired. Participants could always 
proceed to the next question without answering.   
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Considering the fact that both the patient whose image is part of the mole database 
and thereby of this study and the actual participant of the study remain completely 
anonymous, we applied for a waiver from the cantonal ethics commission (Gesuch 
BASEC-Nr. Req-2016-00415) which we received on 25 July 2016. Thereby it was 
stated that the project will be conducted in compliance with the Declaration of  
Helsinki.  
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5. Current Points of View and Development in Diagnostics 
Melanoma detection still remains difficult. Considering the mentioned continuously 
increasing incidence rates,(1) every endeavour has to be made in order to decrease 
mortality and morbidity. The focus thereby lies on secondary prevention, on a better 
early detection. Various technologies more advanced than the common handheld 
magnifiers are under development and some of them have already been tested in 
clinical trials with interesting results.(16, 17) Nevertheless, for a new technology such as 
a new imaging device to be established, more than a few conditions have to be ful-
filled. Individuals with multiple lesions are particularly in the need of good approaches 
in the frame of an accurate routine control of their skin. Building on the global tech-
nology development in general, there are also methods that aim at involving patients 
in the process of melanoma diagnosis.  
This chapter gives a short overview of current points of view and development in di-
agnostics of melanoma. 
5.1. Already Established: Sequential Digital Dermoscopy Imaging   
(„Monitoring“; SDDI)  
Dermoscopy is a form of surface microscopy. Thanks to incident non-polarised light 
rays, a magnifier and immersion oil between the skin and the microscope, it is possi-
ble to examine cutaneous lesions and to say whether or not they are melanocytic.(18) 
The immersion oil makes the epidermis layers more translucent by reducing their re-
flection. With behalf of a handheld magnifier (normally a magnification of x 10 is 
used) this allows a detailed examination of the epidermis, the following dermo-
epidermal junction and to a lesser extent the underlying upper papillary part of the 
dermis and its pigmented structures.(18) This technique enables the examiner to dis-
criminate morphological features which are not visible to the naked eye. Hence, der-
moscopy contributes to a better diagnosis of not only melanoma but nearly all pig-
mented lesions.(18) At the same time, the number of unnecessary biopsies and there-
by the burden of morbidity can be lowered.(12, 16) Dermoscopy has been used by 
many dermatologists for the last two decades and constitutes a meanwhile estab-
lished element in melanoma diagnosis. Further progress in technology and digital 
imaging equipment made it possible to store dermoscopic images. At a later point, 
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the images can easily be retrieved and compared to an earlier picture.(12) This is what 
is called “monitoring”. Sequentially taken images of the same skin lesion are com-
pared in order to assess whether or not a lesion has undergone any significant 
change. With the aid of dermoscopy and the necessary imaging and storing software, 
an assessment of changes in subsurface structures is possible which could not be 
visualized by conventional photography.(12)   
There are two settings in which digital surface microscopic monitoring is frequently 
found: Long-term monitoring and short-term monitoring.(9, 13) Long-term monitoring is 
indicated when atypical nevi have to be monitored in context of regular skin examina-
tion.(13) Often patients with multiple doubtful melanocytic lesions are concerned as 
they have an increased risk of developing melanoma.(12) The thereby monitored le-
sions have usually been classified as nonmelanoma lesions before but are still moni-
tored in order to detect possibly emerging early melanomas as soon as 
possible.(12, 13)   
Short-time monitoring on the other hand is not specially reserved for patients with 
multiple nevi but for any individual lesion remaining doubtful without satisfying the 
dermoscopic criteria of melanoma(9) (surface microscopic features of invasive mela-
noma according to Menzies et. al(18, 19) in the attachment). The appropriate time inter-
val for short-time monitoring has been assessed in different studies with the conclu-
sion in 2008 that a period of three months remains the standard for ST-SDDI not 
leading to an increased risk for the patient.(13, 20) For the LT-SDDI, a follow-up period 
of 6-12 months on average is usual, this often happens in the context of life-long reg-
ular skin examinations.(12) The purpose of this form of mole monitoring is to discover 
it early enough in case a lesion shows change indicating malignancy. Kittler and 
Menzies 2005 contributing to the atlas of dermoscopy defined the forms of change 
and classified them into significant and non-significant (see table 1 below, see illus-
trations 3-8 in subchapter 4.2).   
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Table 1: Classification of changes(12) 
Change Short-term mole monitoring  
(3 months) 
Long-term mole monitoring  
(6-12 months) 
Significant Any other change other than 
the two non-significant changes 
- Asymmetric enlargement 
- Focal changes in pigmentation or  
structure 
- Regression features 
- Change in colour 
Non-significant - Global change in pigmentation 
(for instance solar-induced) 
- Loss or appearance of milia-
like cysts 
- Darker or lighter overall appearance 
- Change in number or distribution of 
brown globules 
- Decrease in number of black dots 
- Disappearance of inflammatory  
reaction 
- Disappearance of small foci of pigment 
network within central portion of the  
lesion and replacement by diffuse brown 
pigmentation 
 
When it comes to short-term monitoring, any other change than two non-significant 
changes are considered worrying. Both increase or decrease in the number of small 
white milia-like cysts in the lesion and an overall change in pigmentation of the lesion 
were determined as non-significant. The latter change is often solar-induced and af-
fects the surrounding skin as well as the lesion itself. Lesions which underwent other 
changes during short-term monitoring require an excision after the monitoring 
period.(12)   
Participants of the survey for the data collection part of this study were taught exactly 
this classification in the tutorial.  
However, dermoscopy does not bear a sensitivity of 100 % in melanoma detection 
either and its successful employment increases with training and growing experience 
of the user.(12, 16) Nevertheless, dermoscopy enhances early detection of melanoma 
and reduces the number of unnecessary biopsies and has therefore become an in-
dispensable tool.(16)       
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Since there is still a considerable amount of melanomas which totally lack specific 
surface microscopic features, dermoscopy is not supposed to be used as sole indica-
tor for excision. Based on the fact that change is a sensitive marker, monitoring be-
comes utterly important adding the time factor as an additional diagnostic 
criterion.(13, 18, 21) Especially incipient melanoma still lacking classic features can be 
detected.(22)    
The fact that not even the most trained dermoscopist would reach 100 % sensitivity 
in melanoma detection underlines the necessity of additional equipment for profes-
sionals. In contrast, the principles of dermoscopy or particularly of dermoscopic moni-
toring are about to be taken to another level, a level gradually accessible to the pa-
tient. This is going to be addressed in the following two subchapters.     
5.2. Emerging Approaches for Professionals 
Various imaging devices have come onto the market during the last few years based 
on different technical approaches. They are about to be addressed and investigated 
in studies and presented and demonstrated to dermatologists and primary care phy-
sicians (PCPs) on congresses, such as in Zurich in September 2016 and 2017. This 
seems necessary because specialists and PCPs are not yet completely familiar with 
all these new possibilities and aids in skin examination.  
Building on the established principle of dermoscopy, the German company FotoFind-
er (Bad Birnbach, Germany) shaped what is also called “Total body imaging”. It de-
veloped a system called “Automated Total Body Mapping” (ATBM®). For the first 
time, a camera automatically takes images of the entire patient, from their head to 
their toes. In the course of this, an integrated laser system along with a so-called 
“Ghost Feature” guarantees that patients are standing in reproducible positions while 
these photographs are taken.(23) This system takes dermoscopic images which are 
rapidly assembled to total body photos, or in other words “total body maps”. These 
mole maps are saved. On the one hand, the system provides a monitoring of many 
existing lesions simultaneously by comparing the images automatically to prior ones 
that were stored, on the other hand, it detects newly emerging nevi. FotoFinder em-
phasises in its brochure that many melanomas develop de novo and not from lesions 
that existed before.(23) Moreover, a software function called Moleanalyzer provides a 
second opinion by calculating a malignancy score for suspicious pigmented 
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lesions.(23) Total body imaging seems to be beneficial particularly for patients with a 
lot of lesions or too many lesions to track otherwise.(4, 17) Compared to manual pho-
tography of the whole body, the FotoFinder system is time saving. So far, studies are 
controversial when it comes to changes of the biopsy rates thanks to total body imag-
ing.(16) One study found out that total body imaging becomes most useful in patients 
older than 50 years where 30 % of new lesions turned out to be melanomas on biop-
sy compared to 1 % in the individuals younger than 50 years.(16) Besides dermosco-
py, total body imaging or mole mapping is becoming more commonplace and is one 
of the most frequently used tools in non-invasive diagnosis of melanoma.(17) If the 
use of these two important techniques is combined, limitations of their singular use 
are optimized.(4) Recently, total body imaging witnessed an evolution towards 3D rep-
resentation of the patient in form of an avatar by combining the so far established 
total body imaging with SDDI which is considered to have a great potential and likely 
to fulfil the criteria of a good imaging system.(4)    
A further tool that has moved into focus is reflectance confocal microscopy (RCM). 
This technique provides a resolution of the skin tissue which can be compared to 
conventional histopathology.(24) As the name already reveals, its mechanism is based 
on reflectance. Backscattering from an outgoing near-infrared laser (830 nm) is de-
tected emanating only from the in focus plane.(24, 25) It is captured by the microscope 
and horizontal black-white images with a high resolution are produced.(24, 25) Highly 
reflective components of the skin such as melanin, collagen and keratin appear bright 
due to their high refractive indices.(25) The skin can be visualised as far down as the 
papillary dermis in depth and cytological atypia as well as displacements in architec-
ture become depictable. For the diagnosis of melanoma and its different subtypes, 
criteria have been worked out and tested for diagnostic accuracy.(24) Amongst them, 
the presence of “pagetoid spread” is one of the most prominent criteria.(24) An estab-
lished company in the field of RCM is MAVIG GmbH (Munich, Germany). With the 
development of their handheld VivaScope 3000, even challenging skin areas for in-
stance in the face can be visualised. In a systematic review Edwards et al. 2017 con-
cluded that the use of VivaScope subsequent to dermoscopy may improve the diag-
nostic accuracy of skin lesions compared to the use of dermoscopy alone, particular-
ly for melanoma.(26) They refer to a study where both sensitivity and specificity of 
melanoma diagnosis were significantly higher for the combined use of dermoscopy 
and VivaScope compared with dermoscopy alone. Furthermore, they mention other 
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possible applications of VivaScope, for instance as a guide to surgery for better mar-
gin delineation and more complete excisions for lentigo maligna or in diagnosis of 
BCC and SCC.(26) Longo et al. 2012 referred to RCM as “in vivo dermatopathology” 
providing a near-histologic resolution directly at the patient’s bedside within a rea-
sonable period of time. Nevertheless, its interpretation requires histopathological un-
derstanding.(24) 
One last as well non-invasive tool to be addressed in this paper is electrical imped-
ance spectroscopy (EIS). It has been found to provide assistance in diagnosing mel-
anoma.(16) An impedance spectrometer measures the opposition to the flow of alter-
nating currents of various frequencies.(16, 27) The system has already proven to be 
able to distinguish between different stages of breast cancer cell lines.(16) The under-
lying idea is that cancer cells have different electrochemical properties than healthy 
cells and tissues.(16) After the scanning of uninvolved surrounding tissue in order to 
get a baseline in context of a calibration, changes in cell shape, size and membrane 
composition can be discovered.(27) Afterwards, an algorithm classifies the examined 
lesion based on the data captured from both the lesion and the surrounding skin.(27) 
Besides the measuring on the surrounding skin before every evaluation, the lesion 
has to be soaked with saline solution for 60 seconds to enhance the contact between 
the skin and the electrodes.(16) This makes the technique time-consuming.(16) An 
emerging EIS-based system is Nevisense (SciBase AB, Stockholm, Sweden). 2014, 
the results of the largest international prospective study of its kind in melanoma de-
tection were published.(28) The study wanted to assess safety and effectiveness of 
the Nevisense system. The results show a sensitivity in melanoma detection of 96.6 
% and a sensitivity of even 100 % in detection of NMSC. The specificity in melanoma 
detection is indicated as 34.4 %.(28) The authors stress that the Nevisense system is 
supposed to be used in moments when a clinician considers biopsy in consequence 
of clinical features or patient history. It is not meant to confirm a clinical diagnosis of 
melanoma. Finally, the authors conclude that Nevisense proved to be an accurate 
and safe device and recommend it to be used in conjunction with the clinical as-
sessment for the risk of a lesion.(28)  
In a study by Rocha et al. published in 2017, the impact of an EIS system in short-
term digital dermoscopy imaging of melanocytic lesions was examined.(29) A prede-
termined protocol was used defining the further procedure after all the included le-
sions had undergone examination with Nevisense and had received an EIS-score. 
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EIS scores of 7-10 were excised immediately, whereas scores of 0-3 as well as 4-6 
had the standard ST-SDDI over a period of 3 months.(29) Scores of 4-6 were excised 
in case any change appeared after 3 months, scores of 0-3 indicating a benign lesion 
that would not even have required SDDI. Amongst these scores no melanoma was 
found. Respecting this protocol, the results of the study show a sensitivity in mela-
noma detection of 100 %. At the same time, the addition of the use of Nevisense re-
duced the need for SDDI by 46.9 %.(29)  
A study concerning the subject of automated classification in skin cancer detection 
which attracted great attention in 2017 should not go unmentioned.(30) Esteva et al. 
tested the performance of a single convolutional neural network using a dataset of 
129’450 clinical images against the performance of 21 board-certified dermatolo-
gists.(30) They demonstrated that a form of artificial intelligence is able to classify skin 
cancer with a level of competence similar to certified dermatologists.(30) While the 
dermatologists normally make their diagnosis including contextual factors beyond 
visual and dermoscopic inspection, this study’s system bases on a huge amount of 
data, even being able to classify many different visual conditions.(30) The authors see 
substantial benefits for the field of primary care practice but also a possible augmen-
tation in clinical decision-making by expert dermatologists.(30) 
5.3. Approaches for Patients: Devices for Smartphones and Applications 
While many of the available products such as dermoscopes for smartphones like 
HandyScope (FotoFinder, Bad Birnbach, Germany) remain rather expensive in pur-
chase for many patients, almost uncountable applications for smartphones have 
been developed lately that are much more affordable or even for free. These various 
applications use different tools to provide their services. The aim of the addressed 
tools is often to provide information or education as well as to aid patients catalogu-
ing and monitoring suspicious lesions. Some of them as well give feedback concern-
ing malignancy.   
This project intends to investigate if patients are able to detect relevant change in 
monitored lesions on their own after being taught what to pay attention to. In practise, 
this would require a device taking pictures of sufficient quality and a software applica-
tion able to store them which is necessary for observation and comparison in the 
context of the monitoring of a lesion. In contrast, many of the emerging applications 
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go further than helping the patients tracking lesions: They provide the nonclinical us-
ers with feedback concerning the likelihood of malignancy.(31) Wolf et al. 2013 evalu-
ated in a much-noticed study four applications without identifying them.(31) Three of 
them used automated algorithms for their feedback. The fourth one sent all the pic-
tures to a board-certified dermatologist for an evaluation corresponding to a form of 
what is called “teledermatology”.(31) In the study of Wolf et al., this last application 
involving teledermatology reached the highest sensitivity.(31) The authors concluded 
that the accuracy of the evaluated smartphone applications for melanoma diagnosis 
was insufficient because 30 % or more of melanomas were classified as unconcern-
ing.(31) They even emphasised that these applications thereby hold the potential to 
harm users.(31)   
Maier et al. 2015 evaluated an application using an algorithm based on the fractal 
theory in comparison to clinical diagnosis and the histopathological result.(32) With the 
aid of fractal analysis methods, irregular shapes and patterns can be described and 
quantified.(32) Since the fractal pattern of normal skin and of a lesion differs, this ap-
proach has been found a method to determine the outgoing risk of a lesion. In the 
study, the application reached a sensitivity of 73 % and a specificity of 83 %. Never-
theless, the scores reached by two independent dermatologists were higher, which is 
in accordance with the results of the study of Wolf et al. in 2013.(31, 32) The authors 
attest some potential to the tool in the future but emphasize at the same time that it is 
to date insufficient to detect melanoma accurately.(32)  
Although the use of these smartphone applications has been discussed controver-
sially amongst dermatologists, they are already being widely used.(32) According to 
recent studies, around 20 % of the individuals aged younger than 50 years have 
used an application to diagnose a skin disease at least once.(33)   
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6. Results 
In total, 47 patients answered the survey. 30 of them participated in the survey giving 
feedback in the main part, 17 of them answered the survey without feedback in the 
main part. In addition, 19 dermatologists, future dermatologists or medical students 
doing an internship in dermatology (“Unterassistenzärzte”) at the University Hospital 
in Zurich opened the survey that had been previously sent to them by email (called 
participants with “dermatological background”).   
A high proportion of the participants did not assess all 30 images of the main survey. 
In a first round, we counted all the assessed images including the ones of partici-
pants interrupting at some point and the ones from participants completing the survey 
separately. In total, 471 images were assessed in the feedback group as well as over 
328 images in the no feedback group. The participants with a dermatological back-
ground contributed 292 assessed images in their feedback containing survey. Re-
sults are shown in table 2.  
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Table 2: Results 
Survey variant Feedback  
derm. background 
Feedback  
patients 
No-Feedback  
patients 
Overall  
patients 
Test Set     
Images 10 10 10 10 
Participants total n 19 30 17 47 
Images assessed 137 230 125 355 
Correct assessments 113 (= 82.48 %) 194 (= 84.35 %) 105 (= 84.00 %) 299 (= 84.23 %) 
Participants  
completed n 
13 22 12 34 
Images assessed 130 220 120 340 
Correct assessments 109 (= 83.85 %) 185 (= 84.09 %) 102 (= 85.00 %) 287 (= 84.41 %) 
M / SD 8.38 (SD: 1.33) 8.41 (SD: 1.26) 8.50 (SD: 1.09) 8.44 (SD: 1.19) 
     
Main survey     
Images 30 30 30 30 
Participants total n 19 30 17 47 
Images assessed 292 471 328 799 
Correct assessments 232 (= 79.45 %) 375 (= 79.62 %) 267 (= 81.40 %) 642 (= 80.35 %) 
Participants  
completed n 
9 14 10 24 
Images assessed 270 420 300 720 
Correct assessments 216 (= 80.00 %) 335 (= 79.76 %) 244 (= 81.33 %) 579 (= 80.42 %) 
M / SD 24.00 (SD: 1.32) 23.93 (SD: 2.89) 24.40 (SD:1.90) 24.13 (SD: 2.49) 
M: Mean, SD: Standard Deviation, n: Number 
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Table 3: Sensitivity, specificity, positive and negative predictive values of subgroups 
 
Feedback 
Patients 
Change No change  Sensitivity 
 
73.40 % 
Change 69 71 140 Specificity  
 
81.17 % 
No change 25 306 331 Positive predictive 
value PPV 
49.29 % 
 94 377 471 (n) Negative predictive 
value NPV 
92.45 % 
 
No Feedback 
Patients 
Change No change  Sensitivity 
 
84.85 % 
Change 56 51 107 Specificity  
 
80.53 % 
No change 10 211 221 Positive predictive 
value PPV 
52.34 % 
 66 262 328 (n) Negative predictive 
value NPV 
95.48 % 
For the determination of sensitivity, specificity and positive and negative predictive value all the as-
sessments in the main survey were counted.   
 
When it comes to statistic features of the patients participating collected at the very 
beginning of the survey, 55.56 % were female and 44.44 % were male. Regarding 
the age distribution, most of the patients (32.61 %) were between 40 and 49 years 
old, 23.91 % were between 50 and 59 years old and 21.74 % between 30 and 39 
years old. Only 10.87 % each were younger than 30 years or older than 60 years. 
26.67 % of the patients participating stated that they were working or used to work in 
any field related to medicine or health care. 95.56 % stated that they have already 
had a mole examined by a doctor, including a PCP. 82.22 % reported to have had at 
least one mole excised before.   
The best result seen over all participants were 29 correctly assessed images out of 
30 in the main survey. It was reached in the patients’ feedback-group. The participant 
Feedback 
derm. background 
Change (+) No change(-)  Sensitivity (a/(a+c)) 
 
72.88 % 
Change (+) 43 (a) 44 (b)  87 (a+b) Specificity (d/(b+d)) 
 
81.12 % 
No change (-) 16 (c) 189 (d) 205 (c+d) Positive predictive 
value PPV (a/(a+b)) 
49.43 % 
 59 (a+c) 233 (b+d) 292 (n)  Negative predictive 
value NPV (d/(c+d)) 
92.20 % 
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was a man aged between 40 and 49 years. He already did well in the test giving the 
correct answer in 9 out of 10 cases. He denied having a job related in any way to the 
health care system. He had already shown moles to a doctor and had already had at 
least one lesion excised.  
6.1. Concordance between Patients and Expert Dermatologist 
The main aim of the data collection part of this paper was to determine the extent to 
which patients are able to assess whether or not a skin lesion had undergone signifi-
cant change themselves. The variable to measure this extent was defined to be the 
overall concordance between the assessments of patients and the expert dermatolo-
gist in the main part of the survey (the preceding test set not included). Out of in total 
799 assessments in the main survey, 642 (= 80.35 %) were correct. When counting 
only cases assessed by patients answering every question of the survey, 579 out of 
720 decisions (= 80.42 %, confidence interval 76.912 – 83.922 %) were correct  
(M = 24.13, SD = 2.49, median = 24.00 (17.00 - 29.00)). The concordance rates be-
tween the different subgroups (feedback group, no-feedback group and participants 
with a dermatological background) were all at about the same level. They ranged be-
tween 79.45 % (participants with dermatological background) and 81.40 % (no-
feedback group) and where all slightly higher when counting only the patients or par-
ticipants who assessed every case (see table 2). The level of concordance we had 
previously considered significant was 90 %, this has consequently been clearly 
missed.  
6.2. Influence of Feedback on the Concordance 
Another question considered in the study design was whether or not performance 
varies with patients getting feedback. In the group without feedback in the main sur-
vey, the reached mean is slightly higher (M = 24.40, SD = 1.897). The difference 
could not be shown to be significant though (t(22) = 0.449, p = .658). The suspected 
improving influence of the repeating feedback after every assessment not only in the 
test set but also in the main part of the survey could consequently not be demon-
strated.   
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Table 4: Comparison of the performance of different subgroups 
Test M SD n 
Survey variant    
    Feedback 23.9286 2.89467 14 
    No feedback 24.4000 1.89737 10 
Sex    
    Male 24.8000 2.69979 10 
    Female 23.6429 2.30742 14 
Profession    
    In or related to health care 24.8333 1.60208 6 
    Other profession 23.8889 2.72005 18 
Prior mole excision(s)    
    None 24.5000 2.12132 2 
    At least one 24.0909 2.56179 22 
M: Mean of correct assessments in the main survey out of 30 cases, SD: Standard deviation, n: num-
ber of participants out of 24 participants who completed the whole survey.  
The t-test for comparison of the means in two independent samples was used to evaluate significance, 
Levene-test assuming homogeneity of variance in all four comparisons conducted. P-values reflect 
two-sided significance for these tests. In the Shapiro-Wilk-Test for the normal distribution in the sam-
ple a value of .107 was calculated.  
6.3. Further Comparisons of the Concordance 
Relying on the few pieces of statistical information collected at the very beginning of 
the survey, the further comparison of the performance of different subgroups did not 
show significant tendencies either, the data sample being small besides (see  
table 4).   
Although men assessed more cases correctly (M = 24.80, SD = 2.700) than women 
(M = 23.64, SD = 2.307), the difference was not significant in the t-test  
(t(22) = -1.129, p = .271).   
Patients that indicated working or having worked in a profession in or related to the 
health care system scored more correct answers (M = 24.83, SD = 1.602) than pa-
tients with different professions. Nevertheless, this result was not significant, either 
(t(22) = -0.798, p = .433).  
Patients who stated having already undergone at least one excision of a mole before 
had a lower mean (M = 24.09, SD = 2.562). This find could not be shown to be signif-
icant either (t(22) = -0.218, p = .830), pointing out that there were only 2 patients that 
had not had a mole excised before among the participants completing the whole sur-
vey and thus being included in this comparison.   
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6.4. Patients’ Attitudes towards Patient Driven Monitoring 
At the very end of the survey the participants were asked whether or not they could 
imagine at all tracking their own moles by using a comparable application. 92.86 % of 
the answering patients stated that they could imagine using such an application per-
sonally. When it comes to the participants with dermatological background the rate of 
approval rises up to 100.00 %.   
Moreover, the response in the conversation with patients was mostly positive. 
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7. Discussion 
7.1. Key Findings 
When it comes to the overall concordance in assessing the images, all the subgroups 
(feedback, no feedback and participants with a dermatological background) were cor-
rect in around 80 % of the cases. This is below the level of 90 % which had previous-
ly been determined as a significant result. Nevertheless, we consider this a respecta-
ble outcome. The main aim of the project was to find out whether digital dermoscopy 
monitoring is feasible by patients themselves after an initial tutorial. This is of interest 
with regard to the tendencies to stronger involve patients in secondary prevention 
and the fact that there are applicable devices and apps (see chapter 5.3) coming on-
to the market. These applications somehow require these investigated competences 
for an effective use and to serve their purpose so far.  
The patients reached results that were similar to the ones of the persons with derma-
tological background. Surprisingly, the patients getting no feedback at all in the main 
survey assessed the most images correctly, this result not being significant though. 
This is not at all what we expected. The slide with the correct answer coming up each 
time, the image of the case again and a repetition of the significant changes might 
have become confusing or have had a tiring effect on the participant in the end by 
seeming overloading. The results cast doubt on the necessity of consistent feedback. 
As far as feedback is concerned, it remains unanswered whether or not for instance 
repeated feedback at the beginning of multiple short teaching sessions or tutorials 
would have the initially expected improving impact.     
Having a look at the predictive values, it is the negative predictive value that attracts 
attention: In all the subgroups rates clearly over 90 % were reached (see table 3). 
This means when participants could not detect a significant change of the mole, in 
most of the cases there actually was none. That is where we see clinical potential: 
Patients should not end up with a false sense of security. It is important that no sus-
picious lesions are wrongly rated as harmless. Clearly, the negative predictive values 
should still be higher and the simultaneously determined positive predictive values 
are very low. Moreover, it has to be borne in mind that predictive values highly de-
pend on the prevalence. In our survey the “prevalence” of significant change might 
have been a bit higher than in a clinical setting.     
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The fact that participants with dermatological background in this survey did not better 
than recruited patients should not be overestimated. The survey had been sent to all 
the doctors including ones that had only just started their formation in dermatology or 
medical students in their penultimate year doing an internship. Moreover, it has to be 
emphasised that the dermatologist (S. W. M.) who assessed and contributed the 
cases is an expert dermatologist with great experience in the field of dermoscopy. 
For expert dermatologists with less routine in the use of dermoscopy, monitoring re-
mains a challenge as well.  
7.2. Comparison to Other Papers  
We found no other project to exactly compare the study part of this paper to. Current-
ly, there is a fast-growing amount of papers which scrutinize or extensively compare 
several applications or address and assess teledermatology with its pros and con-
tras. After a first highlighting of inaccuracies of four applications designated for mela-
noma detection by Wolf et al. in 2013,(31) Kassianos et al. identified 39 applications 
available for individuals as well as PCPs in a review in 2015.(34) For the first time, they 
evaluated in particular the contents and functions of applications and investigated 
whether these apps have been scientifically validated or not. Amongst other things, 
they supposed that applications containing self-monitoring techniques instead of only 
providing information about skin cancer might be more effective when it comes to the 
patients’ self-management.(34) This underlines the estimated significance of self-
monitoring for early diagnosis, change over the time being a sensitive indicator of 
malignancy and of paramount importance when it comes to incipient or featureless 
melanoma.(11, 12, 13) Moreover, they outlined the little evidence based on clinical input 
or research they found and stressed the necessity of further research.(34) They rec-
ommended to give priority to an evaluation of how skin self-monitoring could help 
people assess their changing moles and derive the reasonable help-seeking deci-
sion. At least indirectly our paper investigated in that direction. Nevertheless, Kassi-
anos et al. attest the apps a great potential.(34) In a very recent work from Australia 
published in 2018 about artificial intelligence in dermatology and its likely forthcoming 
availability to both clinicians and patients, Abbott and Smith also take a stand on 
smartphone applications.(35) They state that especially in Australia where melanoma 
incidence is high(2, 3, 4) and access to dermatological care at many places remote, a 
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diagnostic application could increase the likelihood of an earlier diagnosis or encour-
age the patient to seek out medical care sooner.(35) However, they also warn of side 
effects such as poor selection of monitored lesions, neglect of difficultly accessible 
skin areas or false reassurance, mentioning patients’ guidance as an absolute 
need.(35) It should be clear to patients which applications are reliable and accurate.(35) 
Therefore, Abbott and Smith demand effective regulation, binding standards and the 
effort to remove dangerous and inaccurate products from the market even when po-
tentially slowing innovation.(35)     
7.3. Strength and Limitations 
What makes this little paper different from many other papers is the fact that it draws 
on the inclusion of patients in the process of monitoring to evaluate its feasibility for 
patients themselves. Against the background of the discussed emerging applications, 
we consider the question of the paper justified and important when it comes to the 
protection of the user from false reassurance. After having been taught the 
knowledge in the tutorial part of the survey, patients might also be able to balance a 
risk assessment potentially given by an application in a more critical way.    
The conduction of the project turned out to be more difficult than expected, mainly 
when it came to the enrolment of patients. Although many patients took flyers and 
initially signalised their interest and their willingness to complete the survey, the simi-
lar could not be observed in the number of answers despite considerable endeavour. 
Reasons could be the felt absence of a personal need to know, the subjective im-
pression of uselessness for instance in the frame of a good confidence or relation to 
the doctor or a simple lack of time, bearing in mind the completion of the survey as a 
whole could take long. This was mentioned at its beginning and as evident in the re-
sults, there were participants interrupting the survey. We do not want to trace the 
modest willingness back on an adverse attitude towards self-monitoring in general or 
the discussed emerging applications since a clear majority of the participating pa-
tients (92.86 %) stated that they could imagine using such an application in the future 
when completing the survey. Consequence of the difficulties is a low number of cas-
es and thus limited meaningfulness and significance. Nevertheless, the bespoken 
results can be regarded as tendencies but must be interpreted in a speculative man-
ner.   
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Going back to the study design, there is potential to optimise. In the way the survey 
was conducted, the participants had the freedom to complete it on different devices 
such as computers, laptops, tablets or even smartphones, when- and wherever they 
felt like it. Thereby, the same conditions for instance the same viewing quality could 
not be provided at all. On the other hand, making the patients completing the survey 
on a computer screen directly on site after a consultation might have led to even 
fewer completions. Besides the influence of feedback, it might have been interesting 
as well to depict or quantify the effect of the tutorial by creating another group that 
directly starts completing the survey without education. Letting only participants feel-
ing rather or very familiar with assessing cases proceed to the main survey might be 
a source of bias. However, most of the patients answered alike after a first pass of 
the test set without repeating it. Nonetheless, it is likely that there is a selection bias 
since patients were recruited in a specialised consultation and hence consisted of 
individuals already having a certain knowledge about and paying high attention to 
their skin. This could play a role in the explication of the relatively high concordance. 
The performance of completely unaffected individuals might be lower. An additional 
source of recruitment should have been implemented.   
Moreover, what participants assessed in this survey compulsively varies from what 
they would see using any of the applications when it comes to magnification or illu-
mination of images. This applies especially for applications used without any 
dermoscope-like attachment. The results have to be interpreted speculatively.    
Illustration 9: Case 18/30, LT-SDDI, expert assessment: Unchanged.  
Another difficulty might have been to avoid including too difficultly or too easily as-
sessable cases in the survey. The fact that there were both cases that almost all par-
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ticipants answered equally and few cases creating considerable disagreement may 
sustain that doubt (see illustration 9).   
In the feedback variant of the survey, 53.33 % of the participants decided for signifi-
cant change in this case. In the No feedback group, 72.72 % thought the lesion did 
not change significantly. In the group with dermatological background, there was 
complete discord with 50.00 % stating there was significant change and 50.00 % 
stating the opposite. Reasons might be the white-reddish skin type that makes it 
harder to identify the borders as well as the structure of pigmentation. Moreover, the 
lesion might have been depicted a bit twisted in the follow-up compared to baseline. 
  
7.4. Implications of the Paper and Outlook 
Although the expressiveness of the paper is minor, it has been conducted in regard 
of conditions which are currently in considerable motion. New technologies in mela-
noma diagnostics are emerging not only for professionals but also for patients. There 
is a kind of shift in the methods so far used by clinicians in direction of patients, for 
instance when it comes to the monitoring of skin lesions being of enormous signifi-
cance in early diagnosis of melanoma.(12, 13) The smartphone being omnipresent 
among broad levels of the population is supposed to play an important role in this, for 
instance as a device for the self-monitoring of skin lesions.    
In view of the fact that melanoma incidence is tendentially rising,(1, 2, 4) being very 
high for instance in Australia but also in Switzerland and causing a heavy economic 
burden of disease,(3, 4) there is a definite need to find good tools for the earlier detec-
tion in secondary prevention and reducing the health expenses. The dwindling re-
sources in many health care systems make this need even more urgent. However, 
there are several essential criteria a suitable tool needs to fulfil. It should have a high 
diagnostic accuracy, save time and costs, reduce the number of unnecessary biop-
sies and be accessible to a wide range of population subgroups as well as  
PCPs.(4, 16)   
The further investigation on the new applications claimed in many papers(34, 35, 36, 37) 
and the new tools for professionals is indispensable, as well as regulations and bind-
ing standards to ensure patients’ safety and minimise harm. Abbott et Smith mention 
safety features included in the software such as algorithms to identify patients at high 
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risk and to directly guide them to appropriate care as an option.(35) Until then, caution 
is required and the potential benefits of skin cancer apps have to be balanced,(37) pa-
tient guidance is needed.(35) So far, patient education can only be beneficial for the 
use of medical applications and for self-monitoring in general and as this paper and 
the result of its survey indicate, education seems in a tendency feasible and favoured 
by many patients. In times of dwindling resources in many health care systems, pa-
tients have to accept more and more responsibility and as we show, self-monitoring 
might be a promising way for them to do so. For a better significance or a quantifica-
tion of the impact of teaching as well as the feasibility of patient driven monitoring, 
similar studies should be conducted taking up our approach. They should include a 
higher number of patients, and patients as well as unaffected individuals. Maybe they 
should work with specific applications for a better comparability still using a con-
sistent tutorial. However, it might be also interesting to compare the performance of 
participants being taught different tutorials for a better understanding of what the ide-
al tutorial for self-monitoring should look like. Another approach could be to test cri-
teria of change other than the ones from Kittler and Menzies we used in our 
tutorial.(12)   
Even if these applications will not turn out to be the ideal diagnostic tool longed for by 
many, it might have a substantial impact within the scope of escalating costs in many 
health care systems. There is a potential in every tool that trains for a better or more 
regular self-examination.(33) At the latest as far as the tutorial is concerned, it is clear 
that dermatologists will not be replaced, either, but need to use their skills alongside 
advancing technology.(35)    
„No one should die of malignant melanoma“, was the title of a paper published by 
Ackerman in 1985(38) and as described by Rayner et al. 2018, this remains the ulti-
mate goal of research.(35) Even though there is a long way ahead of us, the dis-
cussed new approaches and findings may shorten it if the needed further research is 
conducted. 
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12. Attachments 
 
Attachment 1: Surface microscopic features of invasive melanoma(18, 19) 
Menzies et al. 1996 worked out a method relying on 11 surface microscopic features 
a clinician has to be able to identify in order to diagnose invasive melanoma. They 
divided these features into so-called negative and positive features (see table 5). 
  
Table 5: Menzies’ Method of Diagnosis of Invasive Melanoma  
 
 
 
 
 
 
 
 
 
 
According to this model, an invasive melanoma can be diagnosed if it strictly has nei-
ther of the two negative features and at the same time at least one of the positive 
morphological features. This method was evaluated to provide a sensitivity of 92 % 
and a specificity of 71 % (Menzies et al. 1996). This result has been described as 
reproducible (Menzies et al. 1996).    
 
Precise descriptions of the complete 11 morphological features can be found in:  
Menzies S, Crotty K, Ingvar C, McCarthy W. An Atlas of Surface Microscopy of Pig-
mented Skin Lesions. Sydney, Australia: McGraw-Hill International Book Co; 1996.  
 
Method of Diagnosis of Invasive Melanoma (Menzies et al.1996) 
 Negative Features (Cannot Be Found)  
  Point and axial symmetry of pigmentation  
  Presence of only one single color 
 Positive Features (at Least One Feature Found)  
  Blue-white veil  
  Multiple brown dots  
  Pseudopods 
  Radial streaming  
  Scar-like depigmentation  
  Peripheral black dots/globules  
  Multiple (5-6) colors  
  Multiple blue/gray dots  
  Broadened network  
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Attachment 2: Example of the two-sided flyer used for the enrolment of participants
  
